#GUTCommentary Javier Cubero et al entitled "Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism" via bit.ly/40ifyTv Complutense Cima Universidad de Navarra Halt-RONIN EU project #HCC

Tim Greten presents the landscape of ongoing clinical trials in biliary tract cancer at #LiverCancerSummit 2024 - There are several ongoing and upcoming clinical trials evaluating various immunotherapies for cholangiocarcinoma, including checkpoint inhibitors, bispecific

#GUTImage by Benjamin Green et al on "Immunosuppressive CD29+ Treg accumulation in the liver in mice on checkpoint inhibitor therapy" via bit.ly/3urRSRk Benjamin Ruf Tim Greten

Very proud of Dr. Kylynda C. Bauer, PhD - Happy Birthday 🎉🎁🎊

Don't miss the exciting #ILCA webinar next week discussing cutting-edge AI and spatial technologies for biomarkers discovery in #HCC ILCA Tim Greten Ankur Sharma Julien Calderaro

A preprint of this study NCI Center for Cancer Research is finally out. Here we found DNAJA3, a mitochondrion-associated gene to be genetically contributing to the conversion of fatty liver to MASH and HCC. journals.lww.com/hep/abstract/9…

Interesting study from Mark Yarchoan and colleagues, who tested a neo-antigen vaccine approach plus anti-PD1 in the second line setting (post TKI) and achieved remarkable clinical responses (CR 3/36 and ORR 11/36). More data needed, but promising! rdcu.be/dD3zp

Tim Greten presenting State of the Art Lecture: From Mice to Men and back to Mice: Basic and Translational Research at the 2024 Annual Cholangiocarcinoma Foundation Meeting Donna Mabry Hrones Cholangiocarcinoma Foundation NCI Center for Cancer Research National Cancer Institute

Congratulations to the 2024 Cholangiocarcinoma Foundation Research Fellowship Award recipients. This year CCF funded an unprecedented 11 grants! The awardees: Binbin Li Pilar Acedo Liberalis D Boila Iwan Paolucci E. Balasooriya Davide Povero, PhD, MBA Caitlin Conboy, MD, PhD MRBenmebarek Gordon Morgan E. Raupach

Preparing my talk for #ECIO2024. This will be an interesting event. Looking forward to meeting all my IR colleagues and friends t.ly/4aPX0

The Importance of Health Disparities in Liver Cancer in the Hispanic Population Thank you to ⁦Maureen Umeh⁩ for the invitation and interview ⁦Tim Greten⁩ ⁦Dr. Rob Winn⁩ ⁦Winn Awards⁩ ⁦NIH⁩ ⁦National Cancer Institute⁩ #fox5DC app.box.com/s/2ys3c8bin51i…

So honored to receive this award together with my colleague Katie Kelley.

It has been a great day at #ecio2024 with my friend and colleague Brad Wood and others. Great session on immune-IR.

It's an honor to have awarded the first Innovation Grant to Dr. Tim Greten and Dr. Kelley. We look forward to the progress that comes from it! #cureCCA

What a great talk from Shadin Ghabra describing amazing surgical techniques to develop novel murine HCC models! Very proud of you!

Thank you Cholangiocarcinoma Foundation . Dr. Katie Kelley and I are ready to work with our colleagues to advance research and find new treatment options! youtube.com/results?search…

I call this convincing data

#ENASymp24 Today is your last chance to submit your abstract for Barcelona. eortc.org/ena

Proud to give a keynote lecture on future immunotherapy in HCC at the The Liver Week 2024 in Seoul

We will miss you! Good luck with your new position. I am sure you will be doing great!